Non-technical summary In mammalian skeletal muscle, the coupling between action potential activation and contraction is supposed to be ultimately mediated by the interaction of two ion channels, the L-type calcium channel (so-called dihydropyridine receptor channel) at the transverse tubular system, and the sarcoplasmic reticulum (SR) calcium release channel (so-called ryanodine receptor channel). This paper demonstrates that adult skeletal muscle fibres transfected in vivo with DNA plasmids are able to express functional transgenic dihydropyridine receptor channels. More importantly, the data suggest that transgenic dihydropyridine receptor channels replace native channels in their interaction with SR calcium release channels. Our findings open new avenues for structural and functional studies of the molecular interactions underlying excitation-contraction coupling within the physiologically relevant cellular context of adult mammalian skeletal muscle fibres.
Introduction
In adult skeletal muscle fibres, the release of Ca 2+ from the SR is triggered by the depolarization of the TTS membrane and occurs at localized regions where the TTS and SR membranes come into close contact (Franzini-Armstrong et al. 1999; DiFranco et al. 2002; Novo et al. 2003; Gomez et al. 2006) . The coupling mechanism whereby the TTS depolarization activates the Ca 2+ release from the SR is not completely understood, but it probably involves the interaction between two critically located transmembrane proteins: the DHPR (or L-type calcium channel) at the TTS membrane and the RyR channel at the SR membrane (Rios & Brum, 1987; Rios & Pizarro, 1991; Protasi et al. 1998; Franzini-Armstrong et al. 1999) .
The DHPR is an ion channel with an oligomeric structure composed of five subunits: α1s (Cav1.1), β1a, γ, α2 and δ. The α1sDHPR is known to have a specific binding site for 1,4 dihydropyridines (hence the name), it forms the conducting pathway typical of L-type Ca 2+ channels, and it has been proposed to serve the role of the voltage sensor for the ECC signal transduction (Rios & Brum, 1987; Tanabe et al. 1988; Adams & Beam, 1990; Rios & Pizarro, 1991) . The β1a subunit has been proposed to regulate the trafficking, targeting and activity of α1sDHPR, and to also participate in excitation-contraction coupling (ECC) (Karunasekara et al. 2009 ). The remaining subunits have been less characterized and are thought to play regulatory functions (Catterall, 2000; Ursu et al. 2004; Obermair et al. 2005) .
The discovery of a natural mutant mouse (dysgenic, mdg mouse) lacking the α1sDHPR subunit (Adams & Beam, 1990) and the generation of a transgenic knockout mouse for the RyR1 channel (Takeshima et al. 1994; Buck et al. 1997) boosted the efforts to unveil the molecular control of the ECC process in skeletal muscle. Though these mutations are lethal at birth, the animal models provide a valuable source of embryonic muscle cells (myoblasts) which, after being cultured and/or differentiated into myotubes, have been extensively used to express transgenic variants of the α1s subunit of the DHPR or the RyR1 in the absence of their native counterparts. For example, the role that various domains of the α1sDHPR play both in ECC and on the Ca 2+ ion transport properties of the channel has been investigated in reasonable detail while using dysgenic myoblasts, myotubes and chimeric DHPRs (Tanabe et al. 1990a (Tanabe et al. ,b, 1991 . However, dysgenic myoblasts and myotubes probably lack the precise cellular context that this membrane protein encounters in adult skeletal muscle fibres, thus raising concerns that functional results obtained in vitro may not fully depict physiologically relevant mechanisms as they occur in fully differentiated fibres. Similar caveats can be raised with respect to information regarding RyR1 channel activation and modulation that has been obtained in dyspedic myoblasts and myotubes (Takeshima et al. 1995; Buck et al. 1997; Perez et al. 2005; Bannister & Beam, 2009) .
As a result of the prevalent lethality issues encountered with natural or targeted mutations of proteins critically important physiologically, such as the α1sDHPR and the RyR1 in skeletal muscle, investigators have developed multiple genetic strategies to generate transgenic animals in which the expression or silencing of a gene (conditional mutations) can be triggered at a given point in time during development (Wamhoff et al. 2007 ). An alternative, or complementary, approach to alter the molecular makeup of the triads in skeletal muscle fibres of fully developed animals has recently become possible with the optimization of in vivo transfection strategies which result in the overexpression of substantial quantities of transgenic membrane and/or cytoskeletal proteins in precise target structures of the muscle fibres (DiFranco et al. 2007 (DiFranco et al. , 2009 .
In this paper, we used in vivo electroporation protocols to investigate whether the expression of two EGFP-tagged transgenic variants of the α1sDHPR (EGFP-α1sDHPR-wt and EGFP-α1sDHPR-T935Y) in adult muscle fibres Surface area was calculated from the diameter and the length of the fibres (assuming them to be cylindrical) as measured from images acquired at the beginning of the experiments. a Significantly different from Control (P < 0.05). n is the number of fibres.
results in the functional replacement of their endogenous counterparts. To this end, we comparatively measured I Ca , charge movements and Ca 2+ release in control and transfected fibres under voltage-clamp conditions. Furthermore, we took advantage of the insensitivity to a neutral DHP (isradipine) and the shifted voltage dependence induced by the mutation T935Y on the α1sDHPR channel. Our results suggest that both α1sDHPR variants are correctly targeted to the TTS membranes, functionally operate as conductive Ca 2+ channels, and possibly act as de novo synthesized voltage sensors for the release of Ca 2+ from the SR.
Methods

Biological preparation and fibre selection
Animals were handled according to the guidelines laid out by the local UCLA Animal Care Committee. Sixty-six mice (C57BL) 4-8 months old were used. Killing was performed in deeply anaesthetized animals (halothane) by quick cervical dislocation. FDB and interosseus (IO) muscles from control (non-transfected) and transfected mice were dissected in Tyrode solution. Fibres were enzymatically dissociated as previously described (Woods et al. 2004; Capote et al. 2010) . Average morphological and electrical properties of fibres from control and transfected muscles are given in Table 1 . Only fibres displaying a sharp banding pattern when viewed under bright field illumination were chosen. For transfected fibres, only EGFP-positive fibres displaying a double-banded pattern of EGFP fluorescence (suggestive of protein expression in the TTS membranes) along their entire length were selected (see below and Supplemental Fig. S1 ). In a few cases, EGFP-negative fibres dissociated from electroporated muscles were selected as sham controls to discard potential electroporation effects.
Plasmids and muscle transfection
The full-length cDNA coding for the wild-type (wt) alpha subunit of the dihydropyridine receptor from rabbit skeletal muscle (α1sDHPR; Ca v 1.1) was subcloned from the plasmid pSG5DHPRα1s (Ahern et al. 2001 ) into a modified version of the vector pEGFP-C1 (Clontech Laboratories, Inc., Mountain View, CA, USA) using NheI and NotI restriction enzymes (New England Biolabs, Ipswich, MA, USA). We thus obtained a plasmid coding for the N-terminal EGFP-tagged α1sDHPR (pEGFP-α1sDHPR-wt). Based on evidence demonstrating that mutation T1066Y renders the α1cDHPR channel (Ca V 1.2) insensitive to 1,4 DHPs (He et al. 1997; Walsh et al. 2007) , we engineered an equivalent single point mutation in the α1sDHPR-wt polypeptide. To this end, we used site-directed mutagenesis (Quikchange kit; Stratagene, La Jolla, CA, USA) to create a single amino acid substitution of threonine by tyrosine at position 935 (T935Y), thus generating the plasmid construct pEGFP-α1sDHPR-T935Y (see Discussion and Supplemental Fig. S2 ).
FDB muscles were transfected by in vivo electroporation protocols as described in detail elsewhere (DiFranco et al. 2009) . A total of 50-80 μg of plasmid DNA was used per foot. A period ranging between 2 and 7 weeks was allowed after transfection for the expression of the proteins to be fully established before the muscles were utilized for TPLSM visualization and/or electrophysiological experimentation.
Optical assessment of transgenic protein expression and targeting
The targeting of fluorescent transgenic proteins to subcellular membrane compartments of the muscle fibres was assessed as described previously (DiFranco et al. , 2007 (DiFranco et al. , 2009 ) using a TPLSM system that consists of an upright microscope (BX51WI, Olympus America Inc., NY, USA), a tunable wavelength Chameleon Ti:Sapphire laser (Coherent, Santa Clara, CA, USA), and a BioRad Radiance 2000 Scanning Head (BioRad/Zeiss, Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA). A 20×, 0.95 NA, water-immersion objective was used (Olympus). The targeting of transgenic EGFP-α1sDHPR variants was determined primarily by comparing the localization J Physiol 589.6 of the EGFP fluorescence with that of an endogenous second harmonic generation (SHG) signal that results from the presence of myosin and is known to have a maximum centred at the M-line of each sarcomere DiFranco et al. 2007 DiFranco et al. , 2009 . TPLSM images of EGFP fluorescence were recorded at 545 ± 50 nm and SHG images at 450 ± 50 nm; both signals were elicited by two-photon illumination at 890 nm. The relative sarcomeric position of EGFP and SHG bands was determined in image overlays and/or by comparison of intensity profiles of selected areas in both images.
Biochemical methods to measure transgenic α1sDHPR expression
Transfected muscles were dissociated as described above. Fifty to one hundred fibres expressing EGFP-α1sDHPR-wt (i.e. EGFP-positive fibres) were identified using a custom-built epifluorescence stereo microscope and transferred to Eppendorf tubes containing wash buffer (66 mM Tris-HCl pH 7.4) and a protease inhibitor cocktail (Complete Mini, Roche, Indianapolis, IN, USA). Fibres were extensively washed and allowed to settle at the bottom of the tubes. The supernatant volume was then reduced to 25 μl, and 25 μl of loading buffer (0.5 M Tris-HCl, 4.4% SDS, 20% glycerol, 2% 2-mercaptoethanol, 0.002% bromophenol blue; Loading Buffer 2×, National Diagnostics, Atlanta, GA, USA) were added. The mixture was briefly vortexed and then rotated for 20 min at 4
• C. A similar number of fibres from sham-transfected muscles, or EGFP-negative fibres from transfected muscles, were identically processed and used as controls for the expression of native α1sDHPRs.
The proteins in these samples were separated on 5% SDS-PAGE gels (100 V for 90 min) and transferred to polyvinylidene fluoride (PVDF) membranes (25 V, overnight) for subsequent immunoblotting. Membranes were blocked for 1 h in blocking buffer (4% skimmed milk powder and 2% bovine serum albumin in Tris-buffered saline with 0.05% Tween (TBS-T)). To assess for the expression of native and transgenic α1sDHPR, the membranes were first exposed overnight to primary antibodies. Mouse anti-α1sDHPR (MA3-921, Thermo Fisher Scientific, Waltham, MA, USA; 1:300) or mouse anti-EGFP (B-2, Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:100) both diluted in 4% non-fat milk in TBS-T were used. Following three washes for 3 min in TBS-T, membranes were later exposed to the secondary antibody (goat anti-mouse HRP conjugated; MP Biomedical; 1:2000), diluted in TBS-T, for 2 h. Calsequestrin was used as a protein-loading control. Mouse anti-calsequestrin (MA no. 913, 1:500; Pierce-Thermo, Rockford, IL, USA) was used as the primary antibody. Enhanced chemiluminescence with Immun-Star HRP substrate (Bio-Rad, Hercules, CA, USA) was used to develop all immunoblots. Images were collected using a CCD camera attached to a ChemiDoc chemiluminescent detection system and using Quantity One software (Bio-Rad). Bands corresponding to native and transgenic α1SDHPR were quantified by densitometry using the Quantity One software, and normalized to the calsequestrin signals to account for variations in the total amount of protein in every lane.
Solutions
Tyrode (in mM): 150 NaCl, 2.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 Mops and 10 sucrose. pH was adjusted with NaOH. Solutions 1 and 2 were used to measure Ca 2+ currents and Ca 2+ release, respectively. Charge movement currents were measured using either solution, but only after blocking Ca 2+ currents (see below). The pH of all solutions was adjusted to 7.2 and osmolarity was 300 mosmol (kg H 2 O) −1 . Stock solutions were prepared for 9-ACA (0.5 M in DMSO), isradipine (10 mM in ethanol), TTX (1 mM in H 2 O), verapamil (50 mM in H 2 O), nifedipine (10 mM in ethanol) and CdCl 2 (1 M in H 2 O). Drugs and toxins were added to the TEA-Cl solution from the stock solutions. The final DMSO and ethanol concentrations were 1:1000 and 1:500, respectively. Control experiments showed no detectable effects of the organic solvents at the dilutions used. All chemicals were purchased from Sigma-Aldrich (St Louis, MO, USA).
TEA-Cl
Experiments were performed at room temperature (20-23
• C).
General electrophysiological and optical methods
Dissociated fibres were plated in coverslip-bottomed Petri dishes placed on the stage of an inverted microscope (Olympus IX-71) equipped with a standard epifluorescence attachment. A 480 ± 40/510/555 ± 45 nm (excitation/dichroic/emission) cube was used to excite and collect the emission of EGFP. Bright field and fluorescence images were acquired using a CCD camera. Low-and high-magnification images were obtained with 10× and 100× (1.3 NA, oil immersion) objectives (Olympus), respectively.
A high-voltage two-microelectrode amplifier (TEV-200A, Dagan Corporation, MN, USA) was used to voltage-clamp the fibres and to record Ca 2+ currents (I Ca ) and charge movement currents. Both microelectrodes were filled with intracellular solution (see above) and had resistances of 8-12 M when measured using Tyrode solution as the bath solution. Muscle fibres were impaled under current-clamp conditions in the presence of Tyrode solution; the resting potential was brought to −90 mV by current injection. Only fibres having an initial resting potential of at least −30 mV and requiring <12 nA to be polarized to −90 mV were utilized. After a period of ∼20 min, which allowed for the equilibration of the pipette solution and the myoplasm (Woods et al. 2004) , the Tyrode solution was exchanged for TEA-Cl (see above) and the fibre was voltage-clamped to a holding potential of −90 mV using the amplifier's maximum gain and speed.
Recording of Ca
2+ currents (I Ca )
Ionic currents other than I Ca were eliminated by removing the current carrier and/or using specific blockers. Thus, Na + currents were eliminated with TTX and by exchanging extracellular Na + with TEA. K + currents through the inward and delayed rectifier channels were abolished by replacing K + in the extracellular and intracellular solutions by TEA and Cs + , respectively, and adding Cs + to the extracellular solution. Cl − currents were blocked with 9-ACA.
Families of membrane currents were recorded in response to step voltage pulses (from a holding potential of −90 mV) with amplitudes ranging from 30 to 180 mV and increments of 5-10 mV. A 30 s resting period was allowed between pulses. The command pulses were digitally pre-filtered at 50 kHz in order to minimize oscillations of the voltage-clamp circuit at the on and off of the pulses. In order to obtain calcium currents, linear capacitive and leak currents were digitally subtracted offline from total membrane current records. To this end, the current in response to a small depolarizing pulse (typically 40 mV) was scaled and used for subtraction. We did not use negative pulses with amplitudes larger than 30 mV for subtraction since we found that long-lasting hyperpolarizing pulses (typically >0.5 s in duration) were deleterious for the fibres. I Ca was routinely recorded in external TEA-Cl solution with 12 mM Ca 2+ ; nevertheless, some control experiments in 2 mM extracellular Ca 2+ were also performed. The resulting calcium currents were expressed per unit surface area (μA cm −2 ) and/or per unit capacitance (A F −1 ). The membrane capacitance ( 
, where V 1/2 is the midpoint of the g Ca activation and k is the voltage change required for an e-fold change in conductance.
When required, I Ca was blocked by the addition of Cd 2+ (0.5 mM) or isradipine (1 μM) to the external solution.
The dose-response curve for isradipine was obtained in non-transfected fibres for concentrations up to 1 μM. To this end, peak I Ca currents elicited by +120 mV pulses were measured before and after application of isradipine. Blockage is expressed as the ratio of I Ca measured during isradipine application divided by I Ca measured before treatment. For each concentration tested, the chamber content (0.3 ml) was thoroughly exchanged with 5 ml of isradipine-containing solution (flux rate: ∼1 ml min −1 ). Usually, up to three isradipine concentrations were tested per fibre.
Charge movement measurements
Capacitive currents were recorded in fibres rendered electrically passive by eliminating all ionic currents. Na + and K + currents were eliminated by ion substitution (K + and Na + replaced by TEA and Cs + ) and channel blocking (TTX, TEA, Cs + ). 9-ACA was used to block ClC-1 chloride currents (DiFranco et al. 2011) . We found that the best way to block I Ca in the presence of 12 mM Ca 2+ for charge movement measurements was to add 20 μM nifedipine and 20 μM verapamil to the TEA-Cl solution. Non-linear capacitive currents (charge movement currents; I Q ) were obtained by subtracting capacitive currents recorded in response to negative (hyperpolarizing) pulses from those in response to positive (depolarizing) pulses. For every sweep, both negative and positive pulses (20-50 ms in duration) were applied sequentially 100 ms apart. For pulses of amplitudes larger than +90 mV, hyperpolarizing pulses were halved to avoid damaging the fibres. The charge (Q) mobilized at the onset (Q on ) and at the end (Q off ) of every voltage step was calculated by integration of non-linear capacitive current records (Q = I Q dt). Steady (non-linear) outward currents, prevalent mainly during relatively large depolarizing pulses (>+100 mV), were excluded from the integration for the calculation of Q on . The tabulated value of Q and plotted in Q-V curves was the average of Q on and Q off . Data in Q vs. V m plots were fitted with a Boltzmann equation analogous to the one described for g Ca . indicator rhod-5N (Invitrogen, Carlsbad, CA, USA) following procedures similar to those described elsewhere (Woods et al. 2005) while using the electrophysiological and optical set-up described above. A 535 ± 45/550/600LP (nm) cube was used to excite, and to collect the fluorescence emission, of rhod-5N. The transient changes in rhod-5N fluorescence (Ca 2+ transients) were elicited by 20 ms pulses in fibres equilibrated with internal solution-2 containing 250 μM rhod-5N and bathed in external TEA-Cl. Ca 2+ transients were expressed in terms of dimensionless F/F (Vergara & Bezanilla, 1976; Vergara et al. 1978) . The voltage dependence of Ca 2+ release was assessed by plotting the F/F peak of the Ca 2+ transients as a function of V m . Data in F/F peak vs. V m plots were fitted with a Boltzmann equation analogous to the one described for g Ca .
Ca 2+ fluxes were calculated from F/F transients using a single-compartment kinetic model as previously described (Woods et al. 2005; Capote et al. 2010) , but incorporating the equilibrium parameters for rhod-5N. The K d (403 ± 75, n = 3), and the maximal/minimal fluorescence ratio (178 ± 32, n = 3) were measured in the same optical set-up used for the experiments. The kinetic dissociation constant of the dye (k off , ∼30,000 s −1 ) was estimated in vitro from DM-nitrophen flash photolysis measurements (Escobar et al. 1997; Nagerl et al. 2000) .
Data acquisition and statistical analysis
Optical, current and voltage records were filtered at 2, 1 and 10 kHz, respectively. Data points were sampled every 30 μs, using a data acquisition interface (PCI-6221, National Instruments, TX, USA) and stored into PC memory under program control using a custom software written in LabView (National Instruments). Unless otherwise stated, pooled data are expressed as mean ± standard error (SEM). Data pairs of average I Ca values from pooled data were compared using 2-sample Student's t tests with a (mean1 − mean2) = 0 null hypothesis (Origin Pro8, OriginLab Corp., MA, USA) and deemed significantly different from each other when P < 0.05 while not assuming equal variance unless otherwise stated.
Results
Calcium currents in control mammalian skeletal muscle fibres
We first characterized I Ca in control fibres isolated from non-transfected FDB or IO muscles. Data were obtained in external TEA-Cl with 12 mM Ca 2+ . Figure 1A shows a family of current traces recorded in response to 1 s voltage-clamp pulses to +5, +10, +15, +20, +25, +30, +35, +60 and +70 mV. For these membrane potentials, the relatively slow transient inward currents (I Ca ) were preceded by outward non-linear capacitive components (at the pulse onset), which represent early components of charge movement currents, and followed by inward tail currents (at the pulse off). The I Ca value records reached maximum values (peak I Ca s) which progressively increased in amplitude for depolarizations up to +35 mV, and decreased for further depolarizations. Similarly, the kinetics of activation and decay of I Ca currents were accelerated with depolarizations up to +35 mV, and slowed down for larger voltages. For a depolarization to +30 mV, both the rising and falling phases of I Ca records could be approximately adjusted to single exponential functions with time constants (τ) of 58 and 150 ms, respectively (see inset, Fig. 1A ). The fast tail currents observed at every voltage were significantly larger than the currents observed during the pulses, suggesting that the decay during the pulses did not result from complete inactivation of the Ca 2+ channel, but from other process(es) (Friedrich et al. 2001) . Figure 1B shows the voltage dependence of average peak I Ca obtained from control fibres. The resulting I Ca vs. V m plot is asymmetrical, with a negative slope conductance towards a maximal negative peak value (maximal peak I Ca ) at ∼+35 mV and an ascending limb towards zero current at a E rev of ∼+90 mV. Sizable inward currents were observed with depolarizations to potentials more positive than −10 mV. The maximal peak I Ca values obtained from 21 control fibres, normalized per unit surface membrane area, or capacitance, are −87.1 ± 5.9 μA cm −2 or −20.1 ± 1.1 A F −1 , respectively (Table 2) . These values are in the upper end of the range from 8 to 20 A F −1 published by other laboratories under comparable conditions (Friedrich et al. 1999 Ursu et al. 2004 ). Table 2 also shows that E rev obtained from pooled data was +87.8 ± 2.3 mV. These values were used to calculate the voltage dependence of the g Ca as shown in Fig. 1C . Boltzmann fits of the data yielded a g Ca,max of 1.81 ± 0.10 mS cm −2 (or 0.42 ± 0.02 mS μF −1 ), which is at least twice the value found by another group under similar experimental conditions (Ursu et al. 2004 (Ursu et al. , 2005 ; nevertheless, the Boltzmann parameter k, which in our case is 5.8 ± 0.2 mV (Table 2) , is comparable to that obtained by them.
We also recorded I Ca from fibres isolated 4 weeks after sham transfection of the muscles. In this case, the maximal peak I Ca and E rev were 94.0 ± 6.9 μA cm −2 and 83.0 ± 8.5 mV, respectively (n = 3). Also, the voltage dependence of I Ca and g Ca were indistinguishable from those obtained from non-transfected fibres, demonstrating that electroporation per se did not affect the properties of the I Ca s.
Expression and sub-cellular targeting of EGFP-α1sDHPR-wt
To study the possible effects of overexpressing Ca 2+ channels on the I Ca of adult FDB and IO fibres, we transfected these muscles with a fluorescently tagged α1sDHPR. We used TPLSM to verify the efficiency of transfection and the expression and targeting of EGFP-α1sDHPR-wt. The low-magnification TPLSM image in Fig. 2A shows a typical example of an FDB muscle electroporated in the presence of pEGFP-α1sDHPR-wt. Most fibres of the FDB branch shown are fluorescent, indicating that they are expressing mature EGFP. It can be noted that EGFP fluorescence is present (in a patterned array hardly noticeable at this magnification) along the entire length of the fibres, though more prevalently at the myotendinous ends of the fibres. Also, fluorescence is excluded from the nuclei. From stacks of TPLSM image sections (similar to that in Fig. 2A ) obtained through the entire thickness of FDB or IO muscles, we found that up to 75% of the fibres were effectively transfected using our protocol. Using higher magnification (Fig. 2B) , it was found that the EGFP fluorescence resulting from the expression of EGFP-α1sDHPR-wt is mainly distributed in a double-banded pattern which is reminiscent of the arrangement of the TTS in the mammalian skeletal muscle fibres (DiFranco et al. , 2009 ). These images demonstrate that de novo synthesized EGFP-α1sDHPR-wt molecules are correctly trafficked and targeted to the TTS; remarkably, very little, if any, EGFP fluorescence is observed at the surface membrane. Additional evidence of the correct localization of the EGFP-α1sDHPR-wt to the TTS membranes is provided by comparison of the distribution of EGFP fluorescence bands with that of the intrinsic SHG from the muscle fibres. Figure 2C shows the SHG image acquired simultaneously with the EGFP fluorescence image shown in Fig. 2B . As expected, the superimposition of images in Fig. 2B and C (Fig. 2D) shows that the SHG bands are located in the larger spacing between consecutive EGFP bands. This is better appreciated in Fig. 2E which shows an enlarged view of the area defined by the rectangles in Fig. 2B and C. The relative location of SHG bands and EGFP fluorescent bands is further emphasized in Fig. 2F which shows intensity profiles of the EGFP fluorescence and the SHG signal determined in the rectangles in Fig. 2B and C, respectively. It can be seen that the peak of the SHG bands are located at the centre of the larger spacing between two consecutive EGFP fluorescence bands. It also can be noted that, as demonstrated previously for fibres stained with di-8-ANEPPS , the shorter spacing between EGFP bands are associated with shallower valleys (corresponding with the position of the Z lines), and the deeper valleys are located at the centre of the larger spacing between two consecutive EGFP bands (corresponding to the M lines). Taken together the data in Fig. 2 demonstrate that adult FDB or IO fibres are efficiently transfected with pEGFP-α1sDHPR-wt, and that EGFP-α1sDHPR-wt is correctly targeted to the TTS membranes.
Calcium currents in fibres expressing EGFP-α1sDHPR-wt
I Ca records from EGFP-positive fibres (as assessed by fluorescence microscopy; see Supplemental , indistinguishable E rev (+87.8 ± 2.3 and 86.4 ± 3.7 mV, respectively, see Table 2 ), and the same V m at which the peak I Ca reaches a maximum (∼+35 mV). Surprisingly, in spite of the fact that the expression of EGFP-α1sDHPR-wt was evident optically, the maximum peak I Ca from nine transfected fibres was −96.1 ± 8.3 μA cm −2 (or −19.5 ± 1.6 A F −1 ), which is not significantly different from the respective values in control fibres ( Table 2) . As expected from the similarity of the I Ca vs. V m curves, the voltage dependence of g Ca for control and transfected fibres, as assessed from parameters of Boltzmann fits (Table 2) , are indistinguishable from each other.
The above results indicating that I Ca s from fibres expressing high levels of EGFP fluorescence in the TTS membranes are essentially identical to those from control fibres are intriguing. The simplest explanation for them would be that somehow the transgenically expressed EGFP-α1sDHPR-wt channels may not be properly inserted in the TTS membranes. Alternatively, if these channels were properly inserted, they may not be rendered functional. In either of these cases, the observed I Ca s would result exclusively from functional native α1sDHPR channels. Another, perhaps more appealing, possibility is that the transgenic channels are actually properly inserted in the TTS membranes but that their functional properties are nearly identical to those of the native α1sDHPR. If this was the case, it would be imperative that the number of functional endogenous channels is downregulated by the overexpression of transgenic EGFP-α1sDHPR-wt, such that the total I Ca remains virtually unchanged.
Biochemical assessment of transgenic EGFP-α1sDHPR-wt expression
Our first approach to investigate the above possibilities was to measure the relative quantities of native and transgenic α1sDHPR peptides in EGFP-positive fibres, as assessed from Western blot analysis, and to compare them with the amount of α1sDHPR in fibres from untransfected muscles. Since the native α1sDHPR and the transgenic EGFP-α1sDHPR-wt proteins differ by approximately 27 kDa (the molecular mass of EGFP), we reasoned that they should be distinguishable as separate bands when assayed with anti-α1sDHPR antibody. In addition, the transgenic protein should be exclusively detectable with an anti-EGFP antibody. Figure 4 shows the results from a typical experiment in which blots from a 5% SDS-PAGE gel were tested with antibodies against α1sDHPR, EGFP and calsequestrin. Lanes A and B correspond to samples of fibres from sham-transfected muscles and from muscles transfected with pEGFP-α1sDHPR-wt, respectively. It can be observed that the anti-α1sDHPR antibody recognized only one band (band b) in lane A, which corresponds to an approximate molecular mass (MM) of 170 kDa, close to that previously reported for the truncated form of the DHPR (Leung et al. 1987; De Jongh et al. 1991) three lanes corresponds to calsequestrin, used as loading control.
Densitometry analysis of several blots like the one shown in Fig. 4 demonstrate that the total amount of EGFP-α1sDHPR-wt protein (sum of bands a and b in lane B) yields a normalized density of 1.34 ± 0.32 (n = 5) which is ∼37% larger, albeit not significantly (P > 0.1), than the native α1sDHPR in control fibres (band a in lane A; normalized density = 0.98 ± 0.16, n = 5). On the other hand, the amount of native α1sDHPR is ∼35% smaller (significantly at the 7% level; P < 0.07) in transfected fibres (normalized density = 0.64 ± 0.1, n = 5) as compared with that in sham-transfected fibres. Altogether, these results are compatible with the possibility that the overexpression of EGFP-α1sDHPR-wt results in the downregulation of the expression of the native form of α1sDHPR.
Isradipine sensitivity of I Ca from control and EGFP-α1sDHPR-wt-expressing muscle fibres
In order to directly test whether transgenic channels can be functionally expressed in adult skeletal muscle fibres, we decided first to explore the sensitivity of the endogenous α1sDHPR to isradipine, then to generate and express a putatively isradipine-insensitive transgenic variant of the channel, and finally to investigate the effects of isradipine on I Ca in transfected fibres.
To our knowledge, the dose dependence of the isradipine block of I Ca s in adult mammalian muscle fibres has not been reported previously; thus, we determined the sensitivity of the native α1sDHPR to this drug. Figure 5A shows that isradipine blocks I Ca s in non-transfected FDB fibres with an IC 50 of 174 nM. It can also be seen from the dose-response curve in Fig. 5A that isradipine is able to block ∼93% of the endogenous current at submicromolar concentrations. The effectiveness of isradipine is illustrated by comparing I Ca records obtained with a pulse to +30 mV, in the absence (thin trace, Fig. 5B ) and in the presence of 1 μM of the drug (thick trace, Fig. 5B ) from a non-transfected fibre. In this experiment, ∼95% of the maximum peak I Ca was blocked. Interestingly, I Ca records from another fibre expressing EGFP-α1sDHPR-wt (Fig. 5C ) displays the same sensitivity to isradipine as that from the non-transfected fibre. In addition, I Ca records from EGFP-negative fibres isolated from electroporated muscles (sham controls) were similarly reduced by isradipine. This is illustrated in Fig. 5D , where the blockage produced by 1 μM isradipine on the maximum peak I Ca is compared in control (non-transfected) (n = 2), EGFP-negative (n = 2) and EGFP-α1sDHPR-wt transfected fibres (n = 4). The average percentage I Ca block for these groups of fibres was 93.3 ± 4.8, 95.2 ± 0.3 and 93.0 ± 1.6%, respectively.
Fibres transfected with pEGFP-α1sDHPR-T935Y express isradipine-insensitive I Ca s
As explained in Methods, we engineered pEGFP-α1sDHPR-T935Y in order to encode an isradipine-insensitive Ca 2+ channel (EGFP-α1sDHPR-T935Y). TPLSM images presented in Supplementary  Fig. S3 show that EGFP-α1sDHPR-T935Y is expressed with the same efficiency, and also correctly targeted to the TTS membranes, as demonstrated above for fibres expressing the EGFP-α1sDHPR-wt isoform. A family of I Ca values recorded from an EGFP-positive fibre (i.e. expressing EGFP-α1sDHPR-T935Y) in response to depolarizing pulses (V m from +5 to +40 mV) is shown in Fig. 6A . The maximum peak I Ca in this fibre was 75.5 μA cm −2 (15.4 A F −1 ), a value smaller than the average values found in untransfected fibres or in fibres expressing EGFP-α1sDHPR-wt. In addition, I Ca traces in Fig. 6A display distinct kinetic features (slightly faster activation and significantly slower decay) compared to those of traces obtained at the same potentials in non-transfected fibres (Fig. 1A) . The inset in Fig. 6A illustrates that, as found in untransfected fibres, both the rising and decaying phases of I Ca recorded at +30 mV could be approximately adjusted to single exponential functions with τ values of 44 and 676 ms, respectively. Altogether, these are indications that mutant channels, with properties slightly different than those of endogenous α1sDHPR, may be functionally expressed after transfection with pEGFP-α1sDHPR-T935Y. Pooled data from 16 EGFP-positive fibres expressing EGFP-α1sDHPR-T935Y yielded a maximum peak I Ca of −77.7 ± 5.3 μA cm −2 (−14.5 ± 0.8 A F −1 ), values significantly smaller than those from control fibres and from fibres transfected with EGFP-α1sDHPR-wt channels (Table 2) . Furthermore, the voltage dependence of I Ca obtained from fibres expressing EGFP-α1sDHPR-T935Y (Fig. 6B, filled diamonds) is different to that of equivalent plots obtained from control and EGFP-α1sDHPR-wt-expressing fibres. It displays a more positive voltage for current activation (at approximately 0 mV), significantly different reversal potentials (E rev 99.3 ± 4.1 mV; see Table 2 ), and a slightly more positive potential at which the peak I Ca reaches a maximum (∼+40 mV). The voltage dependence of g Ca from EGFP-α1sDHPR-T935Y-transfected fibres is shown in Fig. 6C (filled diamonds) . When fitted to a Boltzmann function, it yields parameters that differ significantly from most of the parameters obtained in control and EGFP-α1sDHPR-wt-transfected fibres (Table 2) .
Altogether, the above evidence suggests that mutant EGFP-α1sDHPR-T935Y channels are functionally expressed in transfected fibres, and that these channels may have different properties as compared to those from endogenous α1sDHPR or transgenic α1sDHPR-wt channels. The most definitive proof that this is the case is the detection of a significant component of isradipine-insensitive current (I Ca -ins) in fibres transfected with EGFP-α1sDHPR-T935Y, as illustrated in Fig. 6D . In this case, 1 μM isradipine blocked only 45% of the total I Ca . The I Ca -ins could be totally blocked by 0.5 mM Cd 2+ , demonstrating that it is indeed a calcium current transported by L-type channels (data not shown). It should be noted that I Ca -ins (thick trace) shows little temporal decay in comparison with the total I Ca (thin trace). The voltage dependence of peak I Ca -ins is shown in Fig. 6B (open diamonds). It is observed that the maximum peak I Ca -ins was −38.0 ± 4.5 μA cm −2 (−7.0 ± 0.7 A F −1 ). In 14 transfected fibres, we found that the maximum peak I Ca -ins ranged from 30 to 73% of the total I Ca current (data not shown).
The T935Y single point mutation introduced alterations not only in the isradipine sensitivity of the α1sDHPR, but also additional voltage-gating modifications. The voltage dependence of the isradipine-insensitive g Ca (g Ca -ins; Fig. 6C , open diamonds) is more shallow and shifted to the right with respect to those from untransfected fibres and from fibres expressing α1sDHPR-wt. This is quantitatively demonstrated by comparing the parameters of corresponding Boltzmann fits shown in Table 2 . We note that on average the mutation shifted the voltage dependence by approximately 15 mV towards more positive potentials, and decreased the steepness (k) by approximately 30% with respect to the controls. It is difficult to ascertain if the ∼50% of the total g Ca,max which is isradipine-insensitive in transfected fibres is an accurate indication of the relative number of EGFP-α1sDHPR-T935Y channels expressed in the fibres. It would be so, if the single channel conductance was not affected by the mutation.
Since non-transfected, EGFP-negative and EGFP-α1sDHPR-wt transfected fibres display I Ca s with similar overall properties, including isradipine sensitivity, their maximum I Ca values in the presence and absence of 1 μM isradipine were grouped together in order to be compared with those from fibres expressing EGFP-α1sDHPR-T935Y as illustrated in Fig. 7 . Two conclusions can be reached from these data: (a) the maximum peak I Ca is significantly smaller (28%) in EGFP-α1sDHPR-T935Y than that observed in the other group of fibres; and (b) the percentage of I Ca -ins is significantly larger (∼8-fold) in mutant-transfected fibres than in the other group.
Charge movement currents in fibres expressing transgenic α1sDHPR
Since the voltage sensor of α1sDHPR channel is a significant contributor to non-linear charge movements in skeletal muscle fibres, it is reasonable to expect that the expression of transgenic α1sDHPR may be detectable by electrical measurements under voltage-clamp conditions. Consequently, we compared the properties of charge movement currents (I Q ) in control fibres with those in EGFP-positive fibres expressing either EGFP-α1sDHPR-wt or EGFP-α1sDHPR-T935Y. Figure 8A shows typical charge movement records obtained from a control fibre in response to depolarizing voltage pulses ranging in amplitude from 40 to 140 mV, every 20 mV. As expected, the transient currents at the onset (I Q -on) and at the end (I Q -off) of the pulses became comparatively larger and faster for larger depolarizations; in the experiment shown in Fig. 8A , the peak values of I Q -on and I Q -off were 96 and −93 μA cm −2 , respectively, for the 160 mV depolarizing pulse. The inset in Fig. 8A shows that the Q on and Q off associated with every depolarization are approximately equal; this is an implicit property (Q conservation) of charge movement records. Data from transfected fibres expressing EGFP-α1sDHPR-wt and EGFP-α1sDHPR-T935Y are shown in Fig. 8B and C, respectively. They show that charge movement records in fibres transfected with EGFP-α1sDHPR-wt display similar overall features as those in control fibres, including charge conservation between Q on and Q off (data not shown). However, though difficult to assess visually from the I Q records in Fig. 8B and C, in fibres transfected with EGFP-α1sDHPR-wt (Fig. 8B ) they were larger (I Q -on and I Q -off for the 160 mV depolarization were 104 and −110 μA cm −2 , respectively) and slightly slower than those in control fibres. On the other hand, I Q records from fibres transfected with EGFP-α1sDHPR-T935Y were slightly smaller (I Q -on and I Q -off in Fig. 8C were 82 and −96 μA cm −2 , respectively) but significantly slower than those in control fibres.
The proper way to unmask differences in charge movement records in the three populations of fibres (control, and transfected with pEGFP-α1sDHPR-wt and pEGFP-α1sDHPR-T935Y) is to inspect the voltage dependence of Q (in nC cm −2 ) from pooled data as shown in Fig. 8D . The total charge at various voltages was fitted to a Boltzmann equation with the parameters summarized in Table 3 . As it can be observed from the Q vs. V m plots in Fig. 8D , the maximal amount of charge mobilized (Q max ) is significantly larger in transfected fibres in comparison with control fibres. Thus, in fibres expressing EGFP-α1sDHPR-wt or EGFP-α1sDHPR-T935Y, Q max was 62% or 44% larger than in control fibres (see Table 3 ). E, normalized Q-V plots of the same data in D. Control experiments in sham-transfected fibres yielded values for Q max , V 1/2 and k of 167.3 ± 4.6 nC cm −2 , 2.7 ± 1.4 mV and 16.5± 0.8 mV, respectively; these values are not significantly different from those obtained in untransfected fibres. 
a Significantly different from Control (P < 0.05). b Significantly different from EGFP-α1sDHPR-wt (P < 0.05). c Significantly different from EGFP-α1sDHPR-T935Y (P < 0.05). Values in parentheses are the number of fibres. Table 3 for actual values). Moreover, as illustrated by the normalized Q vs. V m plots in Fig. 8E , the voltage sensitivity of charge mobilization in fibres transfected with EGFP-α1sDHPR-T935Y is not identical to that in control fibres. As shown in Table 3 , the value of V 1/2 in the respective Boltzmann distributions is significantly right-shifted by approximately 10 mV (from 5.2 to 15.5 mV) in fibres transfected with the mutant α1sDHPR with respect to control fibres. In addition, the voltage dependence of Q mobilization in fibres expressing EGFP-α1sDHPR-T935Y is less steep than those in both control and EGFP-α1sDHPR-wt transfected fibres (see Table 3 for values and statistical significance). Altogether, the above results suggest that the total amount of DHPR voltage sensor (native plus transgenic) in transfected fibres is larger than in control fibres where only native sensors are present. Furthermore, it is also important to note that the presence of mutant transgenic channels in fibres transfected with EGFP-α1sDHPR-T935Y confers a different voltage sensitivity (less steep and right-shifted) to charge movement records compared with that of native α1sDHPR channels. Similar changes were observed in the I Ca recorded from fibres transfected with EGFP-α1sDHPR-T935Y.
Comparison of Ca 2+ release in control and transfected fibres
Since, besides its operation as a Ca 2+ channel, the α1sDHPR plays an important role as a key molecule in the voltage-sensing transduction that controls the release of Ca 2+ from the SR in skeletal muscle fibres, it is expected that the overexpression of transgenic variants of this channel in the TTS may impact the Ca 2+ release process. Figure 9 show families of Ca 2+ transients (elicited by voltage-clamp depolarizations to −30, −10, +10, +30 and +70 mV) recorded from a control fibre (Fig. 9A) , and fibres expressing EGFP-α1sDHPR-wt (Fig. 9B) or EGFP-α1sDHPR-T935Y (Fig. 9C ). As can be seen in Fig. 9A , the properties of the Ca 2+ transients are non-linearly dependent of the magnitude of the depolarization; but in simple terms, for all membrane potentials above −30 mV, the transients display a rapid rising phase, a peak ( F/F peak ) and a slowly decaying phase towards a relatively steady value which is maintained throughout the duration of the pulse; the change in fluorescence finally returns slowly to the baseline at end of the pulse. For the largest Ca 2+ transient (elicited by a pulse to +70 mV), the value of F/F peak was 0.65, resulting from a Ca 2+ release flux that peaks at 321 μM ms −1 . Figure 9B and C illustrate that Ca 2+ transients of similar magnitudes (0.6 and 0.61) were recorded from fibres expressing EGFP-α1sDHPR-wt and EGFP-α1sDHPR-T935Y, respectively. These peak values correspond to fluxes of 300 μM ms −1 and 304 μM ms −1 , respectively. The only notable peculiarity in the families of Ca 2+ transients shown in Fig. 9 is that almost no release was detected at −30 mV in the fibre transfected with the T935Y mutant channels, suggesting an alteration in the voltage dependence of the Ca 2+ release process in these fibres.
The voltage dependence of the F/F peak of Ca 2+ transients recorded from multiple fibres of the three types is shown in Fig. 9D (pooled data were fitted with Boltzmann functions and the parameters are shown in Table 3 ). It can be seen that the average maximum F/F peak was not changed as a result from the expression of either transgenic α1sDHPR variant ( Fig. 9 ; see Table 3 for values and statistical significance). However, the figure illustrates that there are no apparent shifts in the midpoint of the voltage dependence (V 1/2 ) of the Ca 2+ transients between control fibres and those expressing EGFP-α1sDHPR-wt, but that there was a noticeable right-shift (by >6 mV) in those expressing EGFP-α1sDHPR-T935Y. These observations were found significant, as shown in Table 3 . Curiously, the voltage dependence of Ca 2+ release was slightly less steep in fibres J Physiol 589.6
expressing EGFP-α1sDHPR-wt than in control fibres ( Table 3 ), while that from fibres expressing mutant protein was not altered. Altogether, from the above Ca 2+ release results it can be reasoned that at least a fraction of the voltage sensors for EC coupling were transgenic channels.
Discussion
In this paper, we demonstrate that our in vivo electroporation methods (DiFranco et al. , 2007 (DiFranco et al. , 2009 permit the transfection of plasmids encoding for the α1sDHPR channel into the muscle fibres, which result in the expression and correct targeting of transgenic variants of this protein to the TTS membranes. The general implication of these studies is that they suggest a viable approach to insert functional α1sDHPR channels in the triads of adult muscle fibres while preserving physiological ECC mechanisms. We reach these conclusions based on: (a) optical data demonstrating that the expression of EGFP-α1sDHPR constructs has a pattern that is reminiscent of the structural organization of the TTS; (b) Western blot analysis showing the expression of bona fide transgenic α1sDHPR in transfected fibres; (c) electrophysiological data demonstrating the detection of Ca 2+ currents in transfected fibres which could have only originated from de novo synthesized functional transgenic channels in the TTS membranes; and (d) optical and electrophysiological data showing altered charge movements and Ca 2+ release in transfected muscle fibres. Before investigating the properties of the Ca 2+ currents observed in transfected fibres, we determined the properties of I Ca in untransfected and sham-transfected fibres in order to establish a comparative platform. Most of our experiments were performed with 12 mM Ca 2+ in the external solution because we reasoned that, under these conditions, I Ca should be larger and have a better signal-to-noise ratio than those recorded at the more physiological 2 mM external [Ca 2+ ]. We verified that this is the case: in three fibres tested in 2 mM external Ca 2+ , g Ca was 0.26 ± 0.03 mS μF −1 , which is Table 3 ). The right ordinate axis gives the corresponding peak Ca 2+ release flux in μM ms −1 calculated from a single compartment model (see Methods). Control experiments in sham-transfected fibres yielded values for the Ca 2+ release parameters that were not significantly different from those obtained in untransfected fibres.
approximately one-half of that recorded in 12 mM Ca 2+ (see Table 2 and Supplemental Fig. S4 ). Also, Boltzmann fits of the g Ca vs. V m plot in Fig. S4 yields a value for V 1/2 of +5.41 ± 0.35 mV, which is shifted by approximately 15 mV towards more negative potentials with respect to those obtained in 12 mM external Ca 2+ in control and α1sDHPR-wt expressing fibres ( Table 2 ). The magnitude of the shift in the voltage dependence of I Ca and g Ca is expected for the 10 mM difference in the external [Ca 2+ ] values if a negative surface potential, resulting from a fixed charge layer on the outer surface of the TTS membrane, is assumed to be 'screened' by the higher external [Ca 2+ ] (Hille et al. 1975 ). However, it should be noted that our V 1/2 values in 2 mM external [Ca 2+ ] are still more positive than those obtained under similar conditions by other authors using patch-clamp techniques (Wang et al. 1999; Collet et al. 2003) .
TPLSM image sections illustrate, at the highest attainable optical resolution possible with two-photon microscopy, that transfected EGFP-α1sDHPR constructs are expressed in a double-banded fluorescence pattern that alternates with respect to the single-banded pattern observed with the SHG signal (Fig. 2) . This overall scheme of EGFP fluorescence distribution coincides with the one previously determined by our laboratory, using a variety of markers, to correspond to the TTS membranes in mammalian muscle fibres (DiFranco et al. , 2007 (DiFranco et al. , 2008 (DiFranco et al. , 2009 Woods et al. 2005; Gomez et al. 2006) . Perhaps the most convincing independent evidence supporting this fact is that fibres expressing EGFP-α1sDHPT-wt, displaying image patterns identical to the ones shown in Fig. 2A (and in Supplemental Figs S1 and S2), report voltage-dependent FRET signals when the lipophilic anion DPA − is added to the external solution, thus demonstrating that the EGFP residue in this protein is located within 6-7 nm from the inner leaflet of the TTS membrane (DiFranco et al. 2008) . As expected, the double-pattern of fluorescence exhibited by the overexpression of EGFP-α1sDHPR-wt (Fig. 2) or EGFP-α1sDHPR-T935Y (Supplemental Fig. S3 ) also matches identically the one observed for the endogenous expression of α1sDHPR, as demonstrated using immunohystochemical staining by us (data not shown) and others (Jorgensen et al. 1989; Miller et al. 2006 ) in isolated muscle fibres or muscle sections. Furthermore, even the negligible targeting to the surface membrane of EFGP-α1sDHPR constructs, which is apparent in Fig. 2 and in the Supplemental Fig. S3 , mimics the expression of the native α1sDHPR as evidenced by immunohistochemistry (Jorgensen et al. 1989) . The only observations regarding the overexpression of EFGP-α1sDHPR constructs, as observed with TPLSM, with respect to immunohistochemical imaging of the expression of endogenous α1sDHPR in skeletal muscle fibres, are that the former show slightly more expression in the perinuclear space and in the myotendinous region of some muscle fibres which are not obvious in the latter.
A key aspect of the present work was the design of the novel isradipine-insensitive variant of α1sDHPR, the EGFP-α1sDHPR-T935Y. The rationale for engineering a 1,4 DHP-resistant α1sDHPR was based in previous work from other laboratories showing that mutations in two critical residues (T1066Y and Q1070M) of the transmembrane segment S5 in the repeat III of α1cDHPR significantly decreased the sensitivity of this channel to neutral 1,4 DHPs (Mitterdorfer et al. 1996; He et al. 1997; Ganesan et al. 2005; Walsh et al. 2007) . Since the single mutation T1066Y already results in a large reduction in the DHP sensitivity of α1cDHPR (Mitterdorfer et al. 1996; He et al. 1997) , we decided to create an equivalent single mutation in the rabbit α1sDHPR. To this end, we aligned the amino-acid (aa) sequence of the rabbit α1cDHPR with that of the α1sDHPR (see Supplemental  Fig. S2A ), determined that threonine in position 935 of the rabbit α1sDHPR aa sequence corresponds to the threonine in position 1066 of the α1cDHPR aa sequence, and engineered the T935Y mutation in the α1sDHPR sequence (Supplemental Fig. S2B) .
The results in Figs 1 and 3 (see also Table 2 ) demonstrate that I Ca s recorded in EGFP-positive fibres, isolated from muscles transfected with pEGFP-α1sDHPR-wt, were indistinguishable from those detected in untransfected fibres. This opened the door to question whether the expression of EGFP-α1sDHPR-wt, as visually inferred from the presence of a double-banded fluorescence pattern ( Fig. 2 and Supplemental Fig. S1 ) and from immunoblot analysis (Fig. 4) of EGFP-positive fibres, was necessarily associated with the functional expression of α1sDHPR-wt in the TTS membranes. To directly address this qualm, we engineered pEGFP-α1sDHPR-T935Y which, when transfected into muscle fibres, resulted in the expression of protein targeted to the TTS membrane in a pattern indistinguishable from that of EGFP-α1sDHPR-wt (compare TPLSM images in Fig. 2 and those in Supplemental Fig. S3 ). The existence of prominent I Ca -ins when EGFP-positive fibres are exposed to 1mM isradipine (Fig. 6) can be construed as compelling evidence that both α1sDHPR transgenic variants tested by us (EGFP-α1sDHPR-wt and EGFP-α1sDHPR-T935Y) are functionally expressed in adult fibres. It would be highly unlikely that the overexpression of the wild-type protein generates non-functional channels when the expression of their single point mutated counterpart results in functional ones. Consequently, it is to be expected that significant fractions of the I Ca s recorded from EGFP-positive fibres transfected with pEGFP-α1sDHPR-wt are also carried by transgenic channels. A first corollary to these arguments is that the close similarity between the I Ca s recorded from untransfected fibres and those from fibres expressing J Physiol 589.6 EGFP-α1sDHPR-wt (Figs 1 and 4, Table 2 ) implies that the overall biophysical properties of endogenous and wild-type transgenic α1sDHPR channels are almost identical. A second corollary is that N-tagging of α1sDHPR with EGFP does not significantly alter the channel behaviour, which confirms results obtained previously using myoblasts as an expression system (Grabner et al. 1998) .
The IC 50 value of 174 nM for adult muscle fibres obtained from the isradipine dose-response curve in untransfected fibres (Fig. 5) compares well with the 182 ± 71 nM reported for myotubes and young FDB rat fibres (Beam & Knudson, 1988) . However, our value is widely different to the ∼13 nM obtained by other authors using myoballs (Lazdunski et al. 1988) . The dose-response curve also shows that 96 ± 6% of the endogenous I Ca is blocked with 1 mM of the drug. From these data, and the results in Fig. 6 , we can infer that the T935Y mutation must have conferred significant insensitivity to isradipine to the α1sDHPR channels. In addition, our results show that, besides an increased resistance to isradipine, T935Y mutant channels display alterations in the kinetic properties and in the voltage dependence with respect to their wild-type counterparts (Fig. 6) . Possible changes in the unitary conductance and/or open probability cannot be excluded at this time. Since, as discussed above, it is unlikely that these changes arise from EGFP tagging, in all likelihood these alterations are side-effects of the T935Y mutation. This is indirectly supported by the demonstration that similar kinetic and voltage-dependence changes were observed when α1cDHPR-T1039Y-Q1043M was expressed in cardiomyocytes (Ganesan et al. 2005) .
The total I Ca in fibres expressing EGFP-α1sDHPR-T935Y (Fig. 6A and thin trace in Fig. 6D) should result from the sum of two components: a measured I Ca -ins component (thick trace, Fig. 6D ) and an I Ca -sens component reflecting the activation of endogenous (native) α1sDHPR channels (not shown). The voltage dependence of I Ca (Fig. 6B) illustrates that, in general, fibres transfected with this mutant channel display robust I Ca -ins, but that there must be an I Ca -sens remnant. The question that may be posed regarding these experiments is: did the exogenously expressed channels mix independently with the endogenous ones in the triads? In an attempt to answer this question, we may assume that at every membrane voltage, I Ca (V ) = I Ca -ins(V )+I Ca -sens(V ). Thus, we can obtain I Ca -sens(V ) by subtracting I Ca -ins(V ) from I Ca (V ) in fibres expressing EGFP-α1sDHPR-T935Y and study the voltage dependence of the remaining conductance. The results of this type of analysis are illustrated in Fig. 10 from three fibres specifically studied with this purpose in mind. Figure 10A shows the voltage dependence of the total g Ca (filled diamonds), g Ca -ins (open diamonds) and g Ca -sens (open squares), calculated from their corresponding currents. The striking differences between the voltage-dependent properties of g Ca -sens and g Ca -ins are illustrated in the normalized plot in Fig. 10B . It is possible to infer from this graph that the total g Ca measured in fibres expressing EGFP-α1sDHPR-T935Y display an overall voltage dependence that is intermediate between an endogenous-like component and the mutant-like component. Moreover, the V 1/2 and k of the Boltzmann fits to the g Ca -sens component calculated from Fig. 10A : 24 ± 0.3 and 5.9 ± 1.0 mV, respectively, are not significantly different from the corresponding values in control and wt-transfected fibres (Table 2) . If we take into consideration that at 1 mM isradipine approximately 5-7% of the native current may not be blocked, and that an unknown fraction of the isradipine-resistant current may have been blocked, the above results allow us to conclude that the theoretical expectations from a simple model assuming that transgenic and endogenous α1sDHPR channels are functionally expressed in the triads without mutual interference seem to be fulfilled.
Interesting information was obtained from our comparative analysis of the relative charge mobilized by pulse depolarizations in fibres transfected with transgenic channels with respect to control fibres. In principle, this type of measurement assesses the total amount of α1sDHPR's voltage sensors within the electric field of the TTS membranes, thus providing a reasonable evaluation of the total amount of α1sDHPR protein effectively inserted in these membranes. Consequently, our finding that Q max in transfected fibres was found to be ∼50% larger in transfected fibres than in control ones suggests that de novo synthesized transgenic proteins are likely to be overexpressed at the level of the TTS membrane. Furthermore, the fact that there is ∼10 mV right-shift in the midpoint (V 1/2 ) and a significant reduction in the steepness (k) of the Boltzmann fits to the Q-V plots in fibres transfected with EGFP-α1sDHPR-T935Y (Fig. 8, Table 3 ) is in agreement with the concept that voltage sensors of mutant transgenic channels are physically expressed in the TTS since similar changes were observed in the voltage dependence of g Ca for this mutant. Coincidentally, neither V 1/2 nor k is significantly altered in fibres transfected with EGFP-α1sDHPR-wt (Fig. 8, Table 3 ).
The result that Q max in transfected fibres is ∼50% larger that in untransfected (or sham-transfected) controls is compatible, but not identical, with Western blot analysis showing only ∼37% increase in α1sDHPR protein. We believe that the most likely explanation for this discrepancy is the practical disparity in the levels of protein expression between the fibres used in Q measurements and those used for Western blots. Namely, the relatively small number of fibres used in electrophysiological experiments were selected among those displaying the highest EGFP fluorescence, as observed with a compound fluorescence microscope; in contrast, the selection of 50 or more fibres (using a fluorescence stereomicroscope) for biochemical analysis was bound to contain a significant proportion of fibres in which the levels of transgenic protein expression was lower.
Although the values of Q max reported here for control fibres are comparable to those reported by other laboratories for mammalian muscle fibres (Wang et al. 1999; Collet et al. 2003; Prosser et al. 2009 ), we observed that there is a significant increment in charge mobilization in transfected fibres with respect to control ones (Fig. 8, Table 3 ). However, a remarkable, and intriguing, observation in the present study is that the overexpression of transgenic α1sDHPR variants did not result in a significant increase of I Ca . We know that this is not a general expected outcome since the overexpression of transgenic isoforms of the chloride channel ClC-1 by in vivo electroporation does result in gain of function when expressed in adult skeletal muscle fibres; namely, the chloride conductance in transfected fibres can be increased up to 4-fold with respect to that observed in control fibres (DiFranco et al. 2009 ). Then, we may ask, what are the possible mechanisms that limit g Ca,max ? Though the answer(s) to this important question may not be unique (and will surely require more experimentation), there are two possibilities that can be invoked from the outset. Both of them are based on the premise that α1sDHPR functionality as a Ca 2+ transporter is limited by a factor (or factors) that remained constant in fibres transfected with transgenic α1sDHPR. One of these factors could be the β1a-subunit of the DHPR (β1aDHPR) which has been reported to regulate not only the trafficking and targeting of α1sDHPR to the membrane, but also its functionality as a Ca 2+ channel (Lacerda et al. 1991; Beurg et al. 1997) . Our TPLSM and charge movement results seemingly discard the possibility that the amount of endogenous β1aDHPR present in the muscle fibres might be limiting the expression and targeting of α1sDHPR to the TTS membranes in our experiments. However, it is still possible that the requirements for I Ca functionality may be more stringent, an option that we are currently investigating with co-transfection experiments. An alternative factor could be the RyR1. As suggested, only α1sDHPR channels interacting with the RyR1 are conductive (Dirksen, 2002) ; thus, the constancy of RyR1 at the triads of normal and transfected fibres would determine the number of conductive α1sDHPR, and therefore a limitation in g Ca,max .
We used the low-affinity Ca 2+ indicator rhod-5N (red fluorescence) to measure without interference Ca 2+ release evoked by voltage depolarizations in fibres expressing EGFP-tagged transgenic proteins (green fluorescence). The maximum rate of Ca 2+ release calculated from rhod-5N transients elicited at large depolarizations in control fibres (∼300 μM ms −1 ) was quite comparable with that previously reported by us, using the low affinity calcium indicator Oregon Green 488 BAPTA-5N (OGB-5N) (Woods et al. 2005) , and by another laboratory, using the low-affinity indicator fura-2FF (Ursu et al. 2005) . However, our value is significantly larger than the <50 μM ms −1 estimated by Prosser et al. (2009) from Ca 2+ transients recorded using fluo-4 in the same preparation. We believe that the discrepancy resides mainly in the limitations imposed by the affinity of the indicator in tracking rapid changes in Ca 2+ (Escobar et al. 1997) .
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The most interesting outcome regarding our Ca 2+ release data is the similarity of the maximal rate of Ca 2+ release in the three populations of fibres studied. Namely, that transfection with the two transgenic variants of α1sDHPR had no detectable effects on the maximal ability of the fibres to release Ca 2+ in response to voltage depolarizations, in spite of the significant increase observed in maximal charge mobilized. There are several possible explanations for the observed disparity between charge movements and Ca 2+ . The simplest would be that EGFP-α1sDHPR-wt and EGFP-α1sDHPR-T935Y were effectively expressed in the TTS, but they did not replace endogenous α1sDHPR in the triads. However, this is at odds with the observation that the voltage dependence of the Ca 2+ release was significantly shifted by ∼6 mV in fibres expressing EGFP-α1sDHPR-T935Y with respect to the normal controls (Fig. 9, Table 3 ). Also, fibres expressing EGFP-α1sDHPR-wt did not show shifts in F/F peak vs. V m plots, but they did display less steep voltage dependence (Fig. 9, Table 3 ). Altogether, this evidence suggests that at least a fraction of the Ca 2+ release process in transfected fibres is controlled by transgenic α1sDHPR, thus implying that they were effectively incorporated into functional triads. We propose that the constancy of the Ca 2+ release in transfected fibres is actually a reflection of the fact that the number of RyR1s interacting with α1sDHPR (native or transgenic) is unchanged. This possibility is not only compatible with our Ca 2+ release results but (as discussed above) it may also explain the constancy of I Ca under every condition.
The results in this paper provide substantial experimental support to the concept that the transfection of muscle fibres with plasmids encoding for transgenic variants of membrane proteins (in our case in vivo electroporation of pα1sDHPR variants) results in the effective expression of functional channels in the TTS membranes. Moreover, the tantalizing possibility that the expression of genetically modified constructs results in the alteration of the molecular composition of the triads is a finding of critical importance for future investigations about the mechanisms of voltage transduction in the ECC process in adult mammalian skeletal muscle fibres.
